BREAKING: Pro-Life Win – New Restrictions on Abortion Pill

A federal appeals court has decided to restrict access to a popular abortion pill.

The abortion pill, Mifepristone, was being shipped to people for easy access to abortions.

Mifepristone was used to combat the growing wave of states outlawing abortion.

Thanks to the 5th Circuit Court of Appeals decision, we are one step closer to getting rid of the drug once and for all.

Watch this video by Tom Fitton on Twitter:

The same Biden FDA goons who pushed the shady vaccines pushing chemical abortions by mail…big court victory against this danger to the public health today in Fifth Circuit! https://t.co/eLFauZ9rN1

— Tom Fitton (@TomFitton) August 16, 2023

Check out what NBC News has to say:

While the ruling is a victory for abortion opponents, the Justice Department said it would appeal the decision and the Supreme Court earlier this year issued a stay while the case goes through the appeals process. That temporary pause has allowed the drug to remain widely available.

ADVERTISEMENT

A spokesperson for DOJ said the department “strongly disagrees” with the ruling and “will be seeking Supreme Court review of that decision.”

The FDA-approved regimen for a medication abortion involves a combination of two drugs: mifepristone, which blocks the hormone progesterone, and misoprostol, which induces contractions. A majority of abortions in the U.S. are carried out with the use of these pills, according to a survey conducted by the Guttmacher Institute, a research group that supports abortion rights.

The case originated in Texas, where U.S. District Judge Matthew Kacsmaryk ruled in favor of a group of doctors and medical professionals who oppose abortion and were challenging the FDA’s approval of mifepristone, as well as later regulatory changes that made the drug more available.

One, in 2016, extended the window in which mifepristone could be used to terminate pregnancies from seven weeks gestation to 10 weeks and reduced the number of in-person visits that patients were required to make from three to one. Another in 2019 approved a generic form of the drug, and another in 2021 removed a requirement that mifepristone be dispensed only in clinics, medical offices and hospitals, thereby allowing the drug to be administered via telehealth and sent by mail.

Kacsmaryk, a Trump appointee, issued a ruling suspending the FDA’s 2000 approval of mifepristone, citing in part what he called “evidence indicating FDA faced significant political pressure” to approve the drug more than two decades ago.

The DOJ has voiced its dissatisfaction with the court’s decision.

They hope to bring it to the Supreme Court to have it overruled.

But I think it’s going to blow up in their face.

Once the Supreme Court sees this, I’m confident they are going to ban the pill outright.

🔥 Breaking Now: Court Rules FDA Must Restore Safeguards on Dangerous Abortion Pill That Hurts Women 🔥

It’s Time for the pro-aborts and the Democrat Party to stop pretending to be concerned about women and find real concern that we would see relevant safeguards as important! pic.twitter.com/app6BOarq1

— Frank Pavone (@frfrankpavone) August 16, 2023

🚨 Appeals court rules to restrict abortion pill use pic.twitter.com/IcjP7CY16W

— Ultra Pepe Lives Matter 🐸 (@pepemqtter1) August 16, 2023

Many news outlets are saying this decision is unfavorable.

Obviously, many news outlets have a liberal bias to them.

This is an absolute win.

CBS News has more on the story:

The 5th Circuit’s decision

In the majority opinion written by Elrod, the 5th Circuit panel disagreed with the Biden administration on the question of whether the doctors and medical groups have legal standing to bring their case, a topic that was debated at length during arguments in the spring.

The appeals court concluded that the challengers have standing, except when it comes to the 2019 approval of a generic version of mifepristone, since they showed they are likely to be injured by the FDA’s actions. But the majority also ruled that the challenge to the FDA’s 2000 approval of mifepristone is likely barred by a six-year statute of limitations.

The court, however, allowed claims related to the 2016 and 2021 changes to proceed. The majority found the challengers are likely to succeed on their argument that the FDA’s loosening of the rules violated the federal law governing the agency rulemaking process.

ADVERTISEMENT

“In loosening mifepristone’s safety restrictions, FDA failed to address several important concerns about whether the drug would be safe for the women who use it,” Elrod wrote. “It failed to consider the cumulative effect of removing several important safeguards at the same time. It failed to consider whether those ‘major’ and ‘interrelated’ changes might alter the risk profile, such that the agency should continue to mandate reporting of non-fatal adverse events. And it failed to gather evidence that affirmatively showed that mifepristone could be used safely without being prescribed and dispensed in person.”

The court argued that “the public interest is disserved by a drug that does not afford adequate protections to its users.”

“On this record and at this preliminary stage, the Medical Organizations and Doctors have made a substantial showing that the 2016 Amendments and 2021 Non-Enforcement Decision were taken without sufficient consideration of the effects those changes would have on patients,” Elrod wrote.

In response to the 5th Circuit’s decision, Evan Masingill, the CEO of GenBioPro, which makes the generic version of mifepristone, said the company will use its legal and regulatory tools to ensure continued access to mifepristone.

“We remain concerned about extremists and special interests using the courts in an attempt to undermine science and access to evidence-based medication, as well as attempts to undermine the [FDA]’s regulatory authority,” he said in a statement.

Alexis McGill Johnson, president and CEO of Planned Parenthood Federation of America, criticized the 5th Circuit’s decision and said it shows that mifepristone’s approval remains at risk.

“Pregnant people should be the ones who make decisions about their own health care, and medical professionals should be the ones who make evidence-based decisions about the safety of medications — not judges,” she said in a statement. “The Supreme Court should reject this clearly baseless and political attempt to interfere with our ability to get health care.”

But Susan B. Anthony Pro-Life America, an anti-abortion rights organization, accused the FDA of jeopardizing women’s health by allowing mifepristone to be obtained through the mail.

“Mail-order abortion pills put thousands of women and girls at risk of serious complications from abortion pills every year,” the group’s state policy director Katie Daniel said in a statement. “We won’t rest until the FDA and the profit-driven abortion industry are held accountable for the suffering they’ve inflicted on women and girls, as well as the deaths of countless unborn children.”

BREAKING: The Supreme Court has BLOCKED lower court restrictions on the abortion pill Mifepristone!!!

HUGE WIN FOR WOMEN!

— BrooklynDad_Defiant!☮️ (@mmpadellan) April 21, 2023

Pray for this to pass swiftly to the Supreme Court.

We need more wins!

Take the fight to the leftists and prevent abortions!

#Trump2024